BeStock  
Stocks › Biotechnology › SMMT

Summit Therapeutics SMMT

US equityMarket cap rank #1601BiotechnologyTop Gainers Yesterday
$9.95 −$0.62 (-5.87%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $10.08 +1.31%
Open$10.28
Prev close$10.57
Day range$9.89 – $10.61
Volume7.22M
Market cap$7.96B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts13
Average target$27.57+177.1% vs. price
  • Buy 62%
  • Hold 31%
  • Sell 8%
Low $8.30Now $9.95Avg $27.57High $43.00

Recent rating changes

The last 20 actions on file set price targets from $8.30 to $43.00, averaging $30.29.

DateFirmRatingTarget
19 Nov 2026 Leerink Partners HOLD $11.00
18 Nov 2026 Bernstein SELL $8.30
18 Nov 2026 Leerink Partners HOLD –
17 Nov 2026 H.C. Wainwright HOLD –
16 Nov 2026 Piper Sandler HOLD $16.00
16 Nov 2026 Stifel BUY $37.00
16 Nov 2026 Citi BUY $42.00
16 Nov 2026 H.C. Wainwright HOLD –
16 Nov 2026 Barclays HOLD $18.00
15 Nov 2026 Wells Fargo BUY $30.00
15 Nov 2026 Citi BUY $42.00
15 Nov 2026 Goldman Sachs BUY $43.00
11 Nov 2026 Wells Fargo BUY $30.00
5 Nov 2026 Evercore BUY $34.00
5 Nov 2026 Stifel BUY $37.00
5 Nov 2026 Citi BUY $43.00
5 Nov 2026 H.C. Wainwright HOLD –
4 Nov 2026 Goldman Sachs BUY $43.00
4 Nov 2026 Barclays HOLD $20.00
2 Nov 2026 H.C. Wainwright HOLD –

Discussion

No comments yet — be the first to weigh in on SMMT.

Sign in to join the discussion.

Scroll to Top